Uncovering Institutional Buying In Prime Medicine Inc (NASDAQ: PRME)
Currently, there are 131.16M common shares owned by the public and among those 51.97M shares have been available to trade. The company’s stock has a 5-day price change of -0.37% and -55.35% over the past three months. PRME shares are trading -54.28% year to date (YTD), with the 12-month market performance down to -80.25% lower. […]
Following The Money: Institution’s Growing Stake In Prime Medicine Inc (NASDAQ: PRME)
Prime Medicine Inc (PRME) concluded trading on Thursday at a closing price of $1.24, with 0.46 million shares of worth about $0.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.11% during that period and on April 17, 2025 the price remained unchanged. […]
Tomorrow Is Not Likely To Be Same For Prime Medicine Inc (PRME)
Prime Medicine Inc (PRME) concluded trading on Thursday at a closing price of $7.80, with 5.34 million shares of worth about $41.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -32.93% during that period and on Thursday the price saw a gain of […]